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Cardiac myocyteAdenosine is a naturally occurring nucleoside that has been shown to regulate a variety of functions in the
cardiovascular system. However, the mechanisms in adenosine receptor signaling are not completely
understood. Given that adenosine receptors have been linked to protein kinase C (PKC) in cardioprotection
and caveolae is critical for receptor signaling, we sought to determine whether activation of adenosine A1
receptors induces selective translocation of PKC isoforms to the membrane from the cytosol and whether
activated PKC is targeted to the caveolin-rich plasma membrane microdomains. The freshly isolated adult rat
cardiac myocytes were used to examine PKC isoforms including PKCα, PKCβ, PKCɛ, PKCδ and PKCζ.
Immunoblot analysis revealed that the immunoreactivity for PKCɛ or PKCδ but not for PKCα, PKCβ or PKCζ
increased signiﬁcantly in the membrane fractions from cells pretreated with the selective adenosine A1
receptor agonist 2-chloro-N(6)-cyclopentyladenosine (CCPA, 100 nM) when compared with non-stimulated
cells. The effect of CCPA on PKCɛ or PKCδ translocation was blocked by adenosine A1 receptor antagonist 8-
cyclopentyl-1,3-dipropylxanthine (DPCPX, 100 nM). When Western blot was performed from the caveolin-
enriched plasma membrane fractions, the immunoreactivity for PKCɛ or PKCδ but not PKCα, PKCβ or PKCζ
was enhanced signiﬁcantly by CCPA. Furthermore, PKCɛ and PKCδ were detected in the anti-caveolin-3
immunoprecipitates but not in the samples without primary antibody. Immunoﬂuorescence staining further
indicates increased colocalization of PKCɛ or PKCδ with caveolin-3 at cell peripheral region and T-tubular-
like structures in response to adenosine A1 receptor activation. In conclusion, we demonstrate that activation
of adenosine A1 receptors promotes the selective translocation of PKCɛ and PKCδ to the caveolin-enriched
plasma membrane microdomains in cardiac myocytes.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Adenosine is a natural nucleoside produced from the cardiovas-
cular system and exerts a variety of functions including bradycardia,
hypotension and coronary vasodilation [1]. Adenosine recognizes
speciﬁc cell surface receptors including four adenosine receptor
subtypes (A1, A2A, A2B and A3). All these receptor subtypes are
coupled to guanine nucleotide binding proteins (G proteins). The
most characterized mechanism is the effect on adenylate cyclase. In
addition, another important pathway involving protein kinase C
(PKC) has been postulated to play a key role in adenosine receptor
signaling [2–4].
PKC exists as a family of at least 12 isoforms. PKC isoforms mediate
distinct cellular functions by phosphorylating speciﬁc downstream
target proteins. Substrate speciﬁcity is most likely associated with
subcellular localization of activated PKC isozymes. In the heart, a
variety of signaling molecules have been localized in caveolae [5,6].+1 614 292 9083.
ll rights reserved.Caveolae are small (50 to 100 nm) cholesterol and sphingolipid
enriched “cave”-like invaginations of the surface membrane, very rich
in many of the signaling molecules [7–11]. These microdomains may
act to generate subcellular signaling compartments by recruiting
interacting signaling molecules. Indeed, cardiac myocyte caveolae are
the focal points for activated PKC isoforms and their downstream
signaling molecules [10].
PKC can be activated by either exogenous PMA or endogenous
receptor-mediated signaling. While PMA activates both classical and
novel PKC isoforms, translocation of PKC by distinct receptor signaling
is isoform selective. Adenosine A1 receptor is well known to couple to
inhibitory G proteins, and inhibitory G protein often couple to their
effectors by PKC [2,12,13]. It has been shown that PKCɛ translocation
to cardiac sarcolemma or T-tubular structures is involved in
adenosine receptor-mediated responses [14–16]. Recent evidence
suggests that adenosine A1 receptor activation can selectively modify
phosphatase andmitogen-activated protein kinases (MAPK) activities
in caveolin-rich cardiac membrane fractions [17]. However, it is not
known whether adenosine receptor activation targets translocated
PKC isoforms to the caveolin-rich plasma membrane microdomains.
To determine whether activation of adenosine A1 receptors promotes
translocation and caveolar targeting of speciﬁc PKC isoforms, we
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whether activation of adenosine A1 receptors by CCPA induces
translocation of PKC isoforms to the cell membrane and whether
translocated PKC isoforms by CCPA are targeted to caveolin-rich
plasma membrane microdomains. We focused on examining six
major isoforms of PKC that are known to be expressed in adult rat
cardiomyocytes [18,19]. Our results demonstrate that activation of
adenosine A1 receptors increases immunoreactive membrane PKCɛ
and PKCδ but not PKCα, PKCβ and PKCζ in the caveolin-rich
microdomains.
2. Materials and methods
2.1. Materials
Mouse IgG directed against caveolin-3 and rabbit IgG directed
against PKCɛ, PKCβ1, PKCβ2 or PKCδ were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA). Rabbit IgG directed against PKCαwas
purchased from Cell Signaling Technology (Danvers, MA). Rabbit IgG
directed against PKCζ was purchased from Santa Cruz Biotechnology
or Sigma (St. Louis, MO). The phorbol ester phorbal-12-myristate-13-
acetate (PMA), its inactive congener 4α-PMA, adenosine A1 receptor
agonist 2-chloro-N(6)-cyclopentyladenosine (CCPA) and adenosine
A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX)
were supplied from Sigma. PMA, 4α-PMA, CCPA and DPCPX were all
used at a ﬁnal concentration of 100 nM. DPCPX was applied 5 min
before and during addition of CCPA to cell suspension. All drugs were
dissolved in dimethyl sulfoxide, which did not exceed a ﬁnal
concentration of 0.1%.
2.2. Isolation of cardiomyocytes
Adult rat ventricular myocytes were isolated from adult Sprague–
Dawley rats (250 to 300 g) by enzymatic dissociation [20,21]. In brief,
hearts were excised and retrogradely perfused via the aorta with
oxygenated (100% O2) Tyrode's solution containing (in mM) NaCl
126, KCl 5.4, CaCl2 1.0, MgCl2 1.0, NaH2PO4 0.33, HEPES 10 and
glucose 10 at 37 °C. The perfusate was then changed to a Tyrode's
solution that is nominally Ca2+ free but otherwise has the same
composition. The hearts were perfused with the same solution
containing collagenase for 20 min. Softened ventricular tissues were
removed, cut into small pieces and mechanically dissociated by
trituration. The digested cells were initially stored in a solution
containing (in mM) KCl 20, KH2PO4 10, glucose 10, potassium
glutamate 70, β-hydroxybutyric acid 10, taurine 10, mannitol 5 and
EGTA 5, along with 1% albumin, and then transferred to normal
Tyrode solution. Cells were incubated in Tyrode solution with or
without PMA, 4α-PMA, CCPA or CCPA plus DPCPX for 5 min at 37 °C
prior to homogenization for subsequent biochemical and immuno-
ﬂuorescence experiments.
2.3. Puriﬁcation of caveolin-enriched membrane fractions
Caveolin-rich fractions from adult rat cardiomyocytes were
prepared by using a previously described detergent-free method
with some modiﬁcation [22]. Brieﬂy, freshly isolated cardiomyocytes
were pretreated without or with PMA or CCPA for 5 min at 37 °C. Cells
were then spin down and resuspended in 0.5M sodium carbonate and
homogenized. The homogenate was adjusted to 45% sucrose by
addition of an equal volume of 90% sucrose in MBS (25 mM Mes, pH
6.5/0.15 M NaCl) and placed at the bottom of an ultracentrifuge tube.
A 5–35% discontinuous sucrose gradient (in MBS containing 250 mM
sodium carbonate) was formed above by overlaying with 4 ml of 35%
sucrose (prepared in MBS with 250 mM sodium carbonate) and then
4 ml of 5% sucrose (again prepared in MBS with 250 mM sodium
carbonate). Tubes were centrifuged at 39,000 rpm for 18–20 h in anSW41 rotor. Twelve 1-ml fractions were collected from the top to the
bottom of the gradient for subsequent analysis by Western blot.
Caveolin-rich fractions (fractions 4–6) which contain caveolin but
exclude most other cellular proteins were centrifuged at 40,000×g for
2 h to pellet caveolae, which was then suspended in lysis buffer and
sonicated. Samples were resolved by SDS–PAGE, transferred onto a
nitrocellulose membrane and analyzed by probing with various
antibodies.
2.4. Membrane fractionation and western blotting
Freshly isolated cardiac myocytes were incubated in the presence
and absence of PMA, 4α-PMA, CCPA or CCPA plus DPCPX for 5 min
prior to homogenization. Cell lysates were ﬁrst centrifuged at 1000×g
to get rid of unbroken cells and nucleus. Particulate and cytosolic
fractions were prepared by centrifugation at 27,000×g for 1 h or
45,000×g for 30 min. Immunoblot analysis was carried out as
described previously [23,24]. Brieﬂy, the cytosolic and particulate
fractions were denatured in a sample buffer. Equal amounts of
proteins were loaded and electrophoresed on 10% SDS–polyacryl-
amide gels and transferred onto nitrocellulose membranes. The
transferred blots were blocked with 5% nonfat milk in Tris-buffered
saline (TBS, 150 mM NaCl, 20 mM Tris–HCl, pH 7.4) and incubated for
2 h at room temperature or overnight at 4 °C with primary antibodies
in TBS, 0.1% Tween 20. After washing, the blots were reacted with
peroxidase-conjugated secondary antibodies for 45 min and devel-
oped using the ECL detection system.
2.5. Co-immunoprecipitation
Immunoprecipitation experiments were performed as reported
previously [22,25]. Cells were pretreated with or without CCPA prior
to homogenization. The cell lysate was incubated with or without
antibody against caveolin-3 for 2 h at 4 °C. Antigen–antibody
complexes were captured with r-protein-A agarose (4 °C, 30 min).
Agarose beads were washed 4 times with solubilization buffer before
removal of bound proteins by boiling in SDS sample buffer. Samples
were resolved by SDS–PAGE, transferred onto a nitrocellulose
membrane and analyzed by probing with antibodies against PKCɛ,
PKCδ or caveolin-3.
2.6. Immunoﬂuorescence confocal microscopy
As described previously [22], after pretreated cells with or without
CCPA, the cells were ﬁxed with 4% formaldehyde in PBS for 30 min,
blocked, permeabilized in 5% goat serum in PBS with 0.1% Triton X-
100 (30 min) and labeled with primary antibody for 2 h. Cells were
then washed three times and labeled with ﬂuorescence-conjugated
secondary antibody for 1 h. Immunoﬂuorescence was visualized with
confocal laser scanning microscopy. All images were analyzed using a
background subtraction method ofﬂine.
3. Results
3.1. Effect of PMA on translocation of PKC isoforms from the cytosol to
the particulate fraction
To investigate whether activation of adenosine receptors induces
translocation of PKC isoforms from the cytosol to the particulate
(membrane) fraction, we ﬁrst examined the subcellular localization of
a representative isoform from each PKC subgroup, i.e. PKC-α (the
classic PKC), -ɛ (the novel PKC) and -ζ (the atypical PKC) following
PMA (100 nM) treatment [26]. It is known that PMA activates the
classical and novel but not the atypical PKC isoforms. As expected,
Western blot analysis of cytosolic and membrane fractions separated
by high speed centrifugation from rat cardiomyocytes detected all
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antibody against PKCα revealed a prominent protein band, which
migrated with an apparent molecular mass of ∼80 kDa. Antibody
directed against PKCɛ detected a 90-kDa band while PKCζ was
detected as a protein with a molecular mass of ∼78 kDa and appears
as doublets. Our results revealed that PMA pretreatment (37 °C,
5 min) induced a signiﬁcant redistribution of PKCα and PKCɛ from the
cytosol to the membrane but not PMA-insensitive isoform PKCζ (Fig.
1A). The membrane to cytosol ratios of both PKCα and ɛ increased
approximately threefold in PMA-treated cells when compared with
control group (Fig. 1B). The inactive congener 4α-PMA did not cause
translocation of these PKC isoforms. Thus, we are able to demonstrate
that PMA induces translocation of PKCα and PKCɛ but not PKCζ under
our experimental condition.Fig. 1. Subcellular redistribution of PKC isoforms in response to PMA. (A) Represen-
tative Western blots of three to four independent experiments (three to four hearts).
(B) Membrane to cytosol ratio as indexes of PKC isoform translocation. They were
calculated by relative densitometry and normalized to 100% of control. Soluble and
particulate fractions were prepared from cells incubated at 37 °C for 5 min in the
absence or presence of PMA (100 nM) or 4α-PMA (100 nM). Equal amounts of total
proteins were loaded in each lane, separated by SDS–PAGE and transferred onto
nitrocellulose membranes. Membranes were probed with antibodies directed against
PKCα, PKCɛ or PKCζ and incubated with horseradish peroxidase (HRP)-linked
secondary antibodies. Immunoblots were detected with enhanced chemiluminescence
and multiple exposures to ﬁlm. ⁎pb0.05.3.2. Effect of adenosine A1 receptors on translocation of PKC isoforms
from the cytosol to the particulate fraction
We then determined the effect of adenosine A1 receptors on
subcellular distribution of PKC isoforms. We examined six PKC
isoforms that are present in the adult rat cardiomyocytes, including
PKCα, PKCβ1, PKCβ2, PKCɛ, PKCδ and PKCζ. Cells were incubated
with or without the selective A1 receptor agonist CCPA (100 nM)
or CCPA plus the selective A1 receptor antagonist DPCPX (100 nM)
for 5 min at 37 °C prior to homogenization and fractionation. The
purity of the membrane or cytosolic fractions was examined with
α-tubulin and Na/KATPase (Fig. 2A). Western blot from cell
homogenates revealed signiﬁcant translocation of PKCɛ and PKCδ
from the cytosol to the membrane in CCPA-treated group (Fig. 2B).
It was noted that the CCPA-induced translocation of PKCɛ or PKCδ
was moderate when compared with PMA-treated group. Densito-
metric analysis indicated that the membrane to cytosol ratio was
increased by 79% (179.16±21.52%, n=3, pb0.05 vs. control) for
PKCɛ and 81% (181.26±14.82%, n=3, pb0.05 vs. control) for
PKCδ in response to CCPA (Fig. 2C). When data were normalized to
control within the cytosol or membrane fraction, the CCPA
treatment signiﬁcantly increased membrane-associated immuno-
reactivity by 49% (149.43±10.78%, n=3, pb0.05 vs. control) for
PKCɛ and 66% (166.46±23.18%, n=3, pb0.05 vs. control) for
PKCδ. The signal from the cytosolic fraction was decreased by 16%
for PKCɛ (84.12±7.43%, n=3, p=NS vs. control) and 10% for
PKCδ (90.10±1.40%, n=3, p=NS vs. control). Thus, CCPA produce
a decreased but not statistically different signal in the cytosolic
PKCɛ and PKCδ. Treatment with CCPA plus adenosine A1 receptor
antagonist DPCPX (100 nM) signiﬁcantly prevented CCPA-induced
translocation of PKCɛ and PKCδ. The membrane to cytosol ratio for
PKCɛ was 116.80±8.33% (n=3, p=NS vs. control) and for PKCδ
was 129.48±11.07% (n=3, p=NS vs. control) in the presence of
CCPA and DPCPX. Thus, our data show that CCPA promoted the
selective translocation of PKCɛ and PKCδ, the effect was blocked by
DPCPX. Further, the subcellular distribution of PKCα, PKCβ1 or
PKCβ2 was not altered signiﬁcantly by CCPA treatment, suggesting
that these PKC isoforms may not be as important as PKCɛ and
PKCδ in adenosine receptor signaling in adult rat cardiomyocytes.
As expected, our data also showed that CCPA had no apparent
effect on the redistribution of diacylglycerol-insensitive PKCζ.
These results suggest that activation of adenosine A1 receptors
promotes selective translocation of PKCɛ and PKCδ but not PKCα,
PKCβ or PKCζ to the membrane from the cytosol in the adult rat
cardiomyocytes.
3.3. Effect of adenosine A1 receptors on targeting PKC isoforms to the
caveolin-rich plasma membrane
Translocation to different cellular compartment enables PKC to
colocalize with both activators and substrate. Since adenosine A1
receptors have been shown to reside in the caveolae of cardiac
myocytes [8], we would predict that their downstream signaling
molecules such as PKC isoforms would speciﬁcally target these
microdomains of plasma membrane. We have previously shown
that using a detergent-free sucrose gradient extraction procedure,
the muscle-speciﬁc caveolin-3 isoform is enriched in fractions 4–6
from adult rat cardiomyocytes [22]. Thus, in the present study
caveolin-rich fractions 4–6 were collected to determine alterations
in PKC isoform expression from cardiomyocytes with and without
PMA or CCPA stimulation. The blots were probed with anti-
caveolin-3 antibody to conﬁrm the caveolin-rich fractions. Freshly
isolated adult cardiomyocytes were incubated with PMA (100 nM)
or CCPA (100 nM) for 5 min at 37 °C prior to fractionation. As
shown in Fig. 3A, the antibody against caveolin-3 detected
abundant caveolin-3, a signature protein for the caveolae of
Fig. 2. Subcellular redistribution of PKC isoforms in response to CCPA. (A) Purity of the membrane or cytosol fraction. (B) Representative Western blots of three independent
experiments (three hearts). (C) Membrane to cytosol ratio calculated by relative densitometry and normalized to 100% of control as indexes of PKC isoform translocation. Cells were
incubated without or with CCPA (100 nM) or CCPA plus DPCPX (100 nM) for 5 min at 37 °C and then fractionated into soluble and particulate fractions. The adenosine A1 selective
agonist CCPA induced signiﬁcant translocation of PKCɛ and PKCδ (but not PKCα, PKCβ and PKCζ) from the cytosol to the membrane. The adenosine A1 receptor antagonist DPCPX
prevented CCPA-induced translocation of PKCɛ and PKCδ. Equal amounts of total proteins were loaded in each lane. ⁎pb0.05.
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enrich fractions. Under control condition, only small amounts of
immunoreactivity for all six PKC isoforms were detected in the
caveolin-rich fractions. However, the band intensity for PKCα, PKCβ,
PKCδ or PKCɛ increased signiﬁcantly in response to the stimulation
with PMA. Activation of adenosine A1 receptors with CCPA showed
less but signiﬁcant increase for PKCɛ and PKCδ. Densitometric
analysis revealed that CCPA treatment enhanced the expression of
PKCɛ in the caveolin-rich fraction by 105% (205.59±51.79%, n=3,
pb0.05 vs. control) and PKCδ by 53% (152.50±16.86, n=3,
pb0.05 vs. control), while the levels of immunoreactivity for
PKCα, PKCβ1 or PKCβ2 were not altered signiﬁcantly (Fig. 3B). As
predicted, incubation with either PMA or CCPA did not lead to
the recruitment of diacylglycerol/PMA-insensitive atypical PKCζ
to the caveolin-rich domains. These results indicate that
activation of adenosine A1 receptors promotes rapid association
of PKCɛ and PKCδ with caveolin-rich plasma membrane
microdomains.3.4. Effect of adenosine A1 receptors on co-immunoprecipitation of PKCɛ
and PKCδ with caveolin-3
PKC isoforms have been shown to localize to caveolae and interact
with caveolin in a caveolin-subtype- and PKC isoform-dependent
manner [27,28]. To further determinewhether activated PKCɛ or PKCδ
associates with caveolin-3 in cardiac myocytes and whether this
association can be up-regulated by activation of adenosine A1
receptors, we performed co-immunoprecipitation in the cell lysates
from cardiac myocytes pretreated with or without CCPA (100 nM).
Cell lysates containing equal amounts of total proteins were
immunoprecipitated with anti-caveolin-3 antibody. The immune
complex was collected with protein A agarose beads. Samples were
resolved, transferred and analyzed by immunoblotting with antibody
against PKCɛ, PKCδ or caveolin-3. As shown in Fig. 4, caveolin-3 co-
precipitated with PKCɛ and PKCδ under basal condition. Both proteins
were not detected in the lysates without immunoprecipitation with
anti-caveolin-3 antibody. Interestingly, pretreatment with CCPA
Fig. 3. PKC isoforms translocated to caveolin-rich microdomains in response to stimulation with CCPA. (A) Representative Western blots of three independent experiments from
caveolin-enriched fractions. (B) Expression of PKC isoforms in caveolin-rich fractions calculated by relative densitometry and normalized to 100% of control. Cells were incubated in
the absence or presence of PMA (100 nM) or CCPA (100 μM) at 37 °C for 5 min before processed for puriﬁcation of caveolin-rich fractions. The caveolin-rich fractions 4–6 by sucrose
gradient centrifugation were centrifuged at 40,000×g for 2 h to pellet caveolae, which was then suspended in lysis buffer and sonicated. Equal amounts of caveolae proteins were
loaded and resolved by 10% SDS–PAGE, transferred onto nitrocellulose membrane and analyzed by probing with various antibodies. Similar to PMA, CCPA caused signiﬁcant increase
in the expression of PKCɛ and PKCδ in the caveolin-rich fractions although the degree of targeting PKC isoforms to caveolae by CCPA was less than that by PMA. Caveolin-rich
fractions were veriﬁed by the heavy bands detected by anti-caveolin-3 antibody. ⁎pb0.05.
Fig. 4. Effect of CCPA on co-precipitation of caveolin-3 with PKCɛ or PKCδ. After
pretreatment with or without CCPA (100 nM), cells were homogenized. Cell lysates
containing equal amounts of total proteins were incubated with or without anti-
caveolin-3 (Cav-3) antibody 2 h at 4 °C. Antigen–antibody complexes were captured
with r-protein-A agarose for 30 min at 4 °C. Agarose beads were washed 4 times with
solubilization buffer before removal of bound proteins by boiling in SDS sample buffer.
Samples were resolved by 10% SDS–PAGE, transferred onto nitrocellulose membrane
and analyzed by probing with antibody against PKCɛ, PKCδ or caveolin-3. A smaller
amount of PKCɛ and PKCδ remained constitutively associated with caveolin-3 under the
basal condition. CCPA increased the translocation and association of PKCɛ and PKCδ
with caveolin-3.
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pb0.05 vs. control) and PKCδ by 53% (153.67±7.34%, n=6, pb0.05
vs. control) in the caveolin-3 immunoprecipitates. CCPA did not alter
the recovery of caveolin-3. These data demonstrate that activation of
adenosine A1 receptors with CCPA promotes the translocation and
association of PKCɛ and PKCδwith caveolin-3-rich membrane fraction
in adult rat cardiomyocytes.
3.5. Effect of adenosine A1 receptors on colocalization of PKCɛ and PKCδ
with caveolin-3
To further conﬁrm PKCɛ and PKCδ localize to caveolin-rich
microdomains, we assessed whether both isoforms colocalize with
the marker protein of cardiomyocyte caveolae, caveolin-3, after
stimulation of adenosine A1 receptors with CCPA at 100 nM. Fig. 5
shows confocal immunoﬂuorescence images for PKCɛ, PKCδ and
caveolin-3 from adult rat ventricularmyocytes. These images revealed
that the limited basal levels of PKCɛ and PKCδ were present in the
caveolin-3-associated membrane in the cells without CCPA pretreat-
ment, as indicated by a few yellow punctate staining along the cell
peripherals. The staining pattern with anti-PKCɛ or anti-PKCδ
Fig. 5. Confocal laser microscopic imaging of adult rat cardiomyocytes in response to CCPA. Cells were incubated with or without CCPA (100 nM) for 5 min at 37 °C before they were
subject to permeabilization and immunostaining with antibody against PKCɛ, PKCδ or caveolin-3 (Cav-3). Both PKCɛ and PKCδ was predominantly associated with cytosol in
unstimulated cells but translocated to cell peripherals and T-tubular-like structures on stimulation with CCPA. Results are representative of three independent experiments.
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throughout of cells and also located at cross-striated structures.
Following CCPA stimulation, the antibody against PKCɛ demonstrated
a prominent surface sarcolemmal punctate staining area. The merged
images showed signiﬁcant areas of colocalization for PKCɛ and
caveolin-3 along the cell peripherals, T-tubular-like structures and
cell-to-cell contact. A similar staining pattern of PKCδ by CCPA was
observed except that PKCδ has more pronounced T-tubular staining
when compared with PKCɛ. A total of 40 cells was imaged and
analyzed. While 25% of cells for PKCɛ and 30% for PKCδ showed
signiﬁcant colocalization in the control group, the number of cells
showing colocalization with caveolin-3 in CCPA-treated groups was
increased to 83% for PKCɛ and 73% for PKCδ. These results indicate that
activation of adenosine A1 receptors induces recruitment of PKCɛ and
PKCδ to the caveolin-3-associated plasma membrane domains.
4. Discussion
The present study demonstrated that activation of adenosine A1
receptors promotes targeting of novel PKC isoforms, PKCɛ and PKCδ to
caveolin-rich plasma membrane microdomains. We demonstrated
that activation of adenosine A1 receptors induced a rapid associationof PKCɛ or PKCδ with caveolin-3 in adult rat cardiac myocytes.
Speciﬁcally, we found that activation of adenosine A1 receptors with
CCPA induced the selective translocation of PKCɛ and PKCδ (but not
PKCα, PKCβ and PKCζ) from the cytosol to the membrane.
Importantly, we showed that activated PKCɛ and PKCδ were targeted
to the caveolin-rich plasma membrane microdomains. We have also
showed that PKCɛ and PKCδ colocalize to and associate with caveolin-
3. This observation is consistent with the notion that activated PKC
isoforms are recruited to caveolae via signaling mechanisms that are
distinct among different PKC isoforms.
It is known that membrane-bound translocation of PKC from
cytosol is a hallmark of PKC activation [29]. Translocation to different
cellular compartments enables PKC to colocalize with both activators
and substrates. Individual PKC isoforms are believed to mediate
distinct cell functions. Upon stimulation, they are directed to distinct
subcellular membrane regions by binding to their speciﬁc activated C
kinase. The activated isoforms are anchored close to their particular
substrates. Although pharmacological evidence suggests that adeno-
sine receptors are linked to PKC activation [2,4], limited study has
directly addressed translocation of PKC isoforms by adenosine
receptors. Importantly, no study has ever explored the caveolar
targeting of speciﬁc PKC isoform(s) induced by adenosine receptors.
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receptors on the selective translocation and caveolar targeting of PKC
isoforms. We found that under basal conditions, the level of
immunoreactivity for PKCɛ and PKCδ in cardiomyocyte caveolae was
limited but enhanced signiﬁcantly following stimulation of adenosine
A1 receptors with CCPA. Other PKC isoforms tested including PKCα,
PKCβ and PKCζ were not signiﬁcantly translocated to the cell
membrane from the cytosol by stimulating adenosine A1 receptors.
These observations provide the novel evidence that activation of
adenosine A1 receptors induces the selective translocation of PKCɛ
and PKCδ but not PKCα, PKCβ and PKCζ in adult rat cardiomyocytes
and the translocated PKCɛ and PKCδ are targeted to the caveolin-rich
plasma membrane. We chose a 5-min treatment with CCPA because
our preliminary data showed that 5-min incubation with CCPA
induced the maximum translocation of PKC isoforms.
Although our data demonstrate that activation of adenosine A1
receptors promotes translocation of PKCɛ and PKCδ but not PKCα,
PKCβ and PKCζ, these results do not exclude the possibility that other
adenosine receptors may cause translocation of one or more of these
PKC isoforms. For example, A3 receptors are linked to activation of
PKCδ [30]. It is likely that the same PKC isoforms activated by different
adenosine receptors may associate with distinct downstream signal-
ing pathways and serve distinct roles. It is also possible that activation
of the same adenosine receptors stimulates more than one PKC
isoforms, each serving a different role under certain physiological
conditions [31,32]. In addition to translocation of PKC isoforms, our
ﬁnding indicates the importance of caveolae microdomains in the
adenosine receptor-mediated translocation of PKC. A1 receptor
activation has been shown to increase PKCδ in the membrane fraction
[3] and PKCɛ in the membrane and T-tubules of cardiac myocytes
[14,15]. These observations are consistent with our ﬁnding that
activation of adenosine A1 receptors promotes translocation of PKCδ
or PKCɛ to the caveolin-rich membrane fractions given that caveolae
are also localized to the T-tubules [33]. However, Lester and Hofmann
report that adenosine receptor activation causes translocation of PKCɛ
but not PKCδ [14]. The discrepancy between this study and the
present study may be due to different adenosine receptor agonist
used. We used CCPA (100 nM) which is a selective adenosine A1
receptor agonist while Lester et al. employed N6-(2-phenylisopro-
pyl)-adenosine R-(−)isomer (R-PIA) at 100 μM that could activate
both A1 and A3 receptors as authors claimed. Even though different
PKC isoforms may be targeted to caveolae upon activation, activated
PKC isoforms within caveolae may associate with distinct cellular
functions due to differential targeting of separate populations of
caveolae which may contain different sets of signaling proteins. PKCɛ
and PKCδ are the major Ca2+-independent PKC isoforms and the most
abundant PKC isoform found in the adult rat cardiomyocytes. The
adenosine receptor-induced caveolar targeting of PKCɛ and PKCδmay
have important implications in adenosine-mediated cardioprotection
[18].
It is known that upon activation, PKC isoforms translocate to
multiple subcellular sites including plasma membrane, mitochondria
or nucleus. Differential targeting of activated PKC isoforms to distinct
subcellular localization determines their substrate speciﬁcity. In the
present study, we focused on examining PKC translocation to the
caveolar plasma membrane since the intact caveolae structure in
cardiac myocytes has been shown to be required for the cardioprotec-
tion of ischemic preconditioning [34,35]. Our observation that
adenosine A1 receptors promote the selective translocation of PKCɛ
and PKCδ to caveolar plasma membrane microdomain implies that
caveolae may serve as a focal point for efﬁcient signaling transduction
involving adenosine A1 receptors. Further, both PKCɛ and PKCδ have
generated considerable interest in cardiac signaling because of their
association with ischemic preconditioning [36]. Of particular interest
is the suggestion that a delay in the onset of cardioprotection is due to
the time taken for PKC isoform translocation and that the memory ofpreconditioning is due to PKC dwelling in a translocated state [37].
Nevertheless, our results do not exclude the possibility that activation
of adenosine A1 receptors may promote translocation of PKCɛ or/and
PKCδ to other subcellular sites such as mitochondria or nucleus. In
fact, mitochondrial translocation of PKCɛ has been linked to
cardioprotection although molecular mechanism by which PKCɛ
targets to mitochondria remains elusive [38,39].
In conclusion, our data demonstrate that activation of adenosine
A1 receptor promotes selective translocation and caveolar targeting of
PKCɛ and PKCδ but not PKCα, PKCβ and PKCζ. This ﬁnding provides
new mechanistic insight into our understanding the role of caveolae
in adenosine receptor-mediated PKC signaling and may have
important implication in cardioprotection.
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